Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sebastián, Solé"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sebastián Solé, Sergio Becerra, Claudia Carvajal, Piero Bettolli, Hernán Letelier, Alejandro Santini, Lorena Vargas, Alexander Cifuentes, Francisco Larsen, Natalia Jara, Jorge Oyarzún, Eva Bustamante, Benjamín Martínez, David Rosenberg, Tomas Galván
Publikováno v:
World Journal of Clinical Oncology. 13:813-821
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
World Journal of Clinical Oncology
In the following review we intend to ascertain the optimal neoadjuvant therapy in patients with locally advanced rectal cancer. In 2004, a study revealed that chemoradiotherapy (CRT) resulted in better local control when performed preoperatively rath
Autor:
Hernán Letelier, Claudia C. Carvajal, Eva Bustamante, Alejandro B. Santini, David M. Rosenberg, Sergio Becerra, Francisco Larsen, Lorena Vargas, Richard Feinn, Piero Bettoli, Benjamín Martínez, Sebastián Solé, Tomas Galván, Alexander Cifuentes, Natalia Jara, Jorge Oyarzún, Rajesh V. Lalla
Publikováno v:
Supportive Care in Cancer
Purpose The aim of this study was to assess the efficacy and safety of Dentoxol mouthrinse in reducing the severity of oral mucositis (OM) secondary to radiation therapy (RT) for head and neck cancer. Methods A randomized, double-blind, placebo-contr
Autor:
Sebastián Solé Z., Natalia Jara
Publikováno v:
Revista médica de Chile v.147 n.10 2019
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Atypical Fibroxanthoma is an unusual dermal mesenchymal tumor. It especially affects older adults and occurs in areas of sun exposure. We report a 75 years old male with a history of sun exposure without using a hat presenting with a scalp nodule. An
Publikováno v:
Revista médica de Chile v.147 n.8 2019
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Treatment of spine bone metastases with stereotactic radio-therapy (SBRT) may produce greater pain relief than palliative radiotherapy. Aim: To evaluate the analgesic response to SBRT. Material and Methods: A search was made in an electro
Publikováno v:
Journal of Radiation Oncology. 8:157-162
Patients with gallbladder cancer (GBC) have a dismal prognosis. We investigated outcomes and risk factors for overall survival (OS) in patients treated with radical surgery and adjuvant chemoradiotherapy (CRT). A total of 212 patients with LAGC (⩾p
Autor:
Andrés Vargas, Sebastián Solé
Publikováno v:
Revista médica de Chile v.146 n.1 2018
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Kaposi´s sarcoma (KS) is a rare tumor that affects mainly immunosuppressed and elderly patients. Aim: To describe the features and outcomes of a cohort of patients with different types of KS treated locally with radiotherapy (RT). Patien
Autor:
Juan Carlos Roa, Daniel Alarcón Cano, Enrique Roca, Andrés Yepes, Lena Morillas G, Verónica Pérez Encalada, Pablo González M, Xavier Kon Jara, Sebastian Hoefler, Hanns Lembach, Germán Calderillo Ruiz, Christian Rolfo, Yuri Moscoso, Olga Barajas, Sebastián Solé, Paola Montenegro B, Luis Ubillos, Consuelo Díaz Romero, Hernán De La Fuente, Bettina Müller, Mauricio Mahave, Alejo Lingua, Luis Mas López, José Lobatón, Javiera Torres, Marcela de la Torre, Andrés Andrade G, Marcela Carballido, Viviana Cuartero, Alejandro Padilla Rosciano, Hugo Marsiglia, Juan Manuel O'Connor, Gilberto Schwartsmann, Christian Caglevic, Jean Michel Butte
Publikováno v:
Revista médica de Chile v.144 n.10 2016
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Pancreatic cancer is a malignancy of great impact in developed countries and is having an increasing impact in Latin America. Incidence and mortality rates are similar for this cancer. This is an important reason to offer to the patients the best tre